Skip to content
Login
Search:
CROI Conference
CROI ConferenceCROI Conference
  • About CROI
    • CROI 2027 Important Dates
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • CROI Abstract Categories
    • Abstract Guidelines and Submission
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Who Can Attend
    • Letter Of Invitation (For Visa And Other Purposes)
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
  • Program
    • CROI 2027 Program
    • Our Voices
    • Media
    • Embargo Policies And Press Release Policies
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • About CROI
    • CROI 2026 Preliminary Important Dates and Deadlines
    • CROI Foundation
    • Scientific Program Committee and Community Liaison Subcommittee
    • Funding and Grant Support
    • IAS-USA
    • Policies, Website, and Copyrights
    • Illustrations of HIV, HCV, and SARS-CoV-2 Viruses
    • Contact Us
  • Abstracts
    • Abstract Guidelines and Submission
    • CROI Abstract Categories
    • Assignment of Abstract Copyright to CROI
    • People-First Language and the Use of Appropriate Terminology
  • Presenters
    • Invited Presenters and Moderators
    • Oral Abstract Presentation Guidelines
    • Poster Presentation Guidelines
    • Themed Discussion Guidelines
    • Plain Language Summaries: A Mile-High View at CROI 2026
    • People-First Language and the Use of Appropriate Terminology
    • Letter Of Invitation (For Visa And Other Purposes)
  • Attendees
    • Registration
    • Who Can Attend
    • Media Accreditation and Registration
    • Affiliated and Proximate Activities
    • Frequently Asked Questions
  • Scholarships
    • New Researcher Scholarship
    • International Researcher Scholarship
    • Community Educator and Mentor Scholarships
    • Scholarship Travel
  • Program
    • CROI 2027 Program
    • CROI 2026 Resources
    • Our Voices
    • Media
    • Resources From Prior Years
    • Webcasts
    • Abstracts and ePoster Archive
    • CROI Issues of TAM
  • CROI 2027 Important Dates

Search Results for: node/PEP: Remember Me?

PGT121 COMBINED WITH GS-9620 DELAYS VIRAL REBOUND IN SHIV-INFECTED RHESUS MONKEYS

By Enthusiast Inc MDMarch 5, 2018

…levels, followed by a decline to undetectable levels in peripheral blood, lymph nodes, and colorectal tissue for >8 weeks prior to ART discontinuation. Autologous cellular immune responses were minimal and…

DOLUTEGRAVIR INCREASES B CELLS AND RESTING MEMORY B CELLS IN RV254

By Jimmy He PharmD, DScApril 28, 2020

…and 2NRTIs is the new standard regimen. However, the influence of these drugs on the recovery of immune cells in blood and lymph node (LN) tissue has not been well…

587 – HIV Transcriptional Regulation in the CNS of ART-Suppressed People With HIV

By Jimmy He PharmD, DScMarch 20, 2025

…tissue (spleen, lymph node, gut) from virally suppressed PWH (n=6; undetectable plasma viral load for a median of 3.41 years) were provided by the National NeuroAIDS Tissue Consortium. HIV LTRs…

A Low CD4/CD8 Ratio During Effective ART Predicts Immunosenescence and Morbidity/Mortality

By Enthusiast Inc MDSeptember 29, 2014

…a normal peripheral CD4 count is obtained. The immunologic and clinical characteristics of this clinical phenotype remain undefined. Methodology: We evaluated the associations of the CD4/CD8 ratio with 1) maturational…

PERSISTENCE OF HIV DNA IN TISSUES EARLY AFTER TRANSPLANTATION WITH CCR5Δ32 STEM CELLS

By Enthusiast Inc MDFebruary 15, 2017

…reservoir size in IciStem patients 5 and 11 was investigated. SCT was performed using HLA-matched CCR5Δ32 donors. Before SCT we performed: 1) Phenotypic and genotypic co-receptor tropism analysis 2) Quantification of…

Pyroptosis Drives Both CD4 T Cell Death And Chronic Inflammation In HIV-Infected Lymphoid Tissues

By Enthusiast Inc MDSeptember 29, 2014

…T cell losses occurring in many lymphoid tissues like tonsil and spleen. Methodology: Human lymphoid aggregated cultures (HLACs) were prepared using tonsil and spleen tissue; lymph nodes from consenting HIV-infected…

350 – 3D Chromatin Capture of the HIV Provirus Reveals Epigenetic Regulators of HIV Latency

By Jimmy He PharmD, DScApril 1, 2026

Background Following acute HIV infection, proviral DNA integrates into the genome and becomes latent. However, while the epigenetic mechanisms silencing proviral DNA likely present druggable targets for a cure, they…

DECODING THE TRANSCRIPTIONAL INFLAMMATORY CASCADES THAT MAINTAIN HIV RESERVOIR

By Jimmy He PharmD, DScApril 28, 2020

…characterized by a cascade of inflammatory cytokines followed by a negative feedback loop of anti-inflammatory cytokines, such as IL10, in order to reestablish homeostasis. Interestingly, viruses have evolved mechanisms that…

364 – RV550: Analytic Treatment Interruption After N-803 in Participants on ART Since Acute HIV

By Jimmy He PharmD, DScMarch 31, 2026

…analytic treatment interruption (ATI). Methods RV550 is a 3-step clinical trial that enrolled participants in AHI. In Step 1, participants received ART alone or ART + N-803 (6 mcg/kg every…

HIV-2 IMPACT ON LYMPHOID ORGANS: EVIDENCE OF VIRAL REPLICATION AND TISSUE DISRUPTION

By Enthusiast Inc MDMarch 5, 2018

The ability of HIV to replicate in secondary lymphoid organs (SLO) and disrupt lymph node (LN) architecture are considered main determinants of disease progression. HIV-2+ individuals feature slow rate of…

←1
23456789101112131415161718192021222324252627282930313233343536373839404142434445464748
…4950515253…
5455565758596061626364656667686970717273747576777879808182
83→
Copyright © 2026 CROI Foundation/IAS-USA. All Rights Reserved.
Website by Enthusiast, Inc.
  • About CROI
  • Presenters
  • Abstracts
  • Scholarships
  • Program
Footer Menu
Go to Top